Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Transmitted beta-cell dysfunction as a cause for type 2-diabetes].

Bernard Portha1

  • 1Groupe Régulations métaboliques et diabètes, Laboratoire de Physiopathologie de la Nutrition, Cnrs UMR 7059, Université Paris 7-Denis Diderot, 2, place Jussieu, 75251 Paris Cedex 05, France. portha@paris7.jussieu.fr

Medecine Sciences : M/S
|November 1, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quinolinic acid protects mouse liver from high-fat diet induced MASLD by inhibiting lipid uptake gene expression.

European journal of pharmacology·2025
Same author

Role of Sphingosine Kinase 1 in Glucolipotoxicity-Induced Early Activation of Autophagy in INS-1 Pancreatic β Cells.

Cells·2024
Same author

Oral administration of kynurenic acid delays the onset of type 2 diabetes in Goto-Kakizaki rats.

Heliyon·2023
Same author

Editorial: Understanding the gene expression of β cell dysfunction in diabetes.

Frontiers in endocrinology·2022
Same author

Glucocorticoid-Induced Hyperinsulinism in a Preterm Neonate with Inherited <i>ABCC8</i> Variant.

Metabolites·2022
Same author

Kynurenine-3-monooxygenase expression is activated in the pancreatic endocrine cells by diabetes and its blockade improves glucose-stimulated insulin secretion.

Biochimica et biophysica acta. Molecular basis of disease·2022
Same journal

[CREPT: An ally of immunotherapy for the fight against non-small-cell lung cancers].

Medecine sciences : M/S·2026
Same journal

[A new regulatory mechanism of HIF-1α: the ROS-ATM-CHK2 axis at the core of tumor angiogenesis].

Medecine sciences : M/S·2026
Same journal

[Vibrio-host interactions: from the environmental niche to virulence].

Medecine sciences : M/S·2026
Same journal

[RcsF, hyperconnected sentinel of the bacterial envelope].

Medecine sciences : M/S·2026
Same journal

[Single-cell RNA-sequencing: shattering the clone myth].

Medecine sciences : M/S·2026
Same journal

[No, Physarum blobs do not have 720 sexes!]

Medecine sciences : M/S·2026
See all related articles

The Goto-Kakizaki rat model reveals three key factors contributing to type 2 diabetes: genetic defects, gestational programming, and chronic hyperglycemia. Understanding these mechanisms can help identify new therapeutic targets.

Area of Science:

  • Endocrinology
  • Genetics
  • Metabolic Diseases

Background:

  • Insulin release and pancreatic beta-cell mass are critical in type 2 diabetes development.
  • Maturity-onset diabetes of the young involves single-gene disorders affecting beta-cells.
  • The genetic basis for common adult type 2 diabetes is less understood, but abnormal beta-cell function is characteristic.

Purpose of the Study:

  • To review the Goto-Kakizaki (GK) rat model for insights into type 2 diabetes pathogenesis.
  • To identify genes and environmental factors contributing to type 2 diabetes risk using rodent models.

Main Methods:

  • Selective breeding of glucose-intolerant Wistar rats to create the GK rat model.
  • Review of existing information from studies on the GK rat.

Related Experiment Videos

Main Results:

  • The GK rat model exhibits heritability of defective beta-cell mass and function.
  • Three pathogenic players are proposed: genetic loci for impaired insulin secretion, gestational metabolic programming affecting beta-cell mass, and secondary loss of beta-cell differentiation due to glucotoxicity.

Conclusions:

  • Understanding beta-cell failure mechanisms in the GK model can reveal therapeutic targets.
  • This research aids in developing strategies for type 2 diabetes prevention and treatment.